BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9757515)

  • 1. [Urinary incontinence in neurogenic defects and urogenital anomalies in childhood].
    Steiner G; Müller SC; Brühl P
    Wien Med Wochenschr; 1998; 148(13):299-304. PubMed ID: 9757515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary diversion and orthotopic bladder substitution in children and young adults with neurogenic bladder: a safe option for treatment?
    Stein R; Fisch M; Ermert A; Schwarz M; Black P; Filipas D; Hohenfellner R
    J Urol; 2000 Feb; 163(2):568-73. PubMed ID: 10647686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of therapy and rehabilitation of patients with urinary incontinence].
    Zermann DH; Lindner H; Huschke T; Schubert J
    Z Arztl Fortbild (Jena); 1996 Oct; 90(6):533-7. PubMed ID: 9036695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurogenic urinary incontinence: current treatment concepts].
    Madersbacher H
    Urologe A; 1990 Jul; 29(4):176-84. PubMed ID: 2205038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuro-urology--development of a new focus in rehabilitation of the spinal cord injured patient].
    Madersbacher H
    Rehabilitation (Stuttg); 1992 Aug; 31(3):147-50. PubMed ID: 1410775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continent urinary diversion in neurogenic bladders].
    Aboutaieb R; el Moussaoui A; el Fatimi A; el Mrini M; Benjelloun S
    Ann Urol (Paris); 1996; 30(2):72-5. PubMed ID: 8767811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continent urinary diversion and the exstrophy-epispadias complex.
    Surer I; Ferrer FA; Baker LA; Gearhart JP
    J Urol; 2003 Mar; 169(3):1102-5. PubMed ID: 12576862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary incontinence in the aged].
    Haschek H
    Z Gerontol; 1984; 17(4):233-8. PubMed ID: 6485483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and urodynamic spectrum of bladder function in cerebral palsy.
    Richardson I; Palmer LS
    J Urol; 2009 Oct; 182(4 Suppl):1945-8. PubMed ID: 19695619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter evaluation of urinary incontinence management and outcome in spina bifida.
    Lemelle JL; Guillemin F; Aubert D; Guys JM; Lottmann H; Lortat-Jacob S; Moscovici J; Mouriquand P; Ruffion A; Schmitt M
    J Urol; 2006 Jan; 175(1):208-12. PubMed ID: 16406913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage procedures to achieve continence after failed bladder exstrophy repair.
    Cervellione RM; Bianchi A; Fishwick J; Gaskell SL; Dickson AP
    J Urol; 2008 Jan; 179(1):304-6. PubMed ID: 18006018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder neck closure in children: a decade of followup.
    Landau EH; Gofrit ON; Pode D; Jurim O; Shenfeld OZ; Duvdevani M; Gross EM; Merguerian PA; Katz R
    J Urol; 2009 Oct; 182(4 Suppl):1797-801. PubMed ID: 19692069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of urinary incontinence and functional fecal incontinence (encopresis) in children.
    Nijman RJ
    Gastroenterol Clin North Am; 2008 Sep; 37(3):731-48, x. PubMed ID: 18794006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
    Klaphajone J; Kitisomprayoonkul W; Sriplakit S
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele.
    Kajbafzadeh AM; Moosavi S; Tajik P; Arshadi H; Payabvash S; Salmasi AH; Akbari HR; Nejat F
    Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary incontinence in children: suggestions for definitions and terminology.
    Hjälmås K
    Scand J Urol Nephrol Suppl; 1992; 141():1-6; discussion 18-9. PubMed ID: 1609244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentation cystoplasty and/or continent urinary diversion. Review of eleven cases].
    Daher P; Zeidan S; Ghorayeb Z; Lteif J
    J Med Liban; 2001; 49(4):192-6. PubMed ID: 12416500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.